Your host took a (he believes) well-earned break in Europe last week following some work over there (and no it wasn’t for the NHS). I’m actually still there (here?) having randomly found wi-fi in a wi-fi less world before my flight back to the states tomorrow. Anyway, I did all the eastern Europe touring I should have done 20 years ago when I lived here, and I recommend Prague heartily.
The main thing of interest that happened while I was gone was that the rumors of IDX’s problems in the UK (mentioned several times in the excellent HISTalk blog) indeed were true. Fujitsu, the general contractor in the southern region fired them, even though their replacement (another win for Cerner) has had its own issues with the "meet and greet" appointment system. (Yeah I know it’s not called that).
Cerner’s stock price is up some 30% since March, which suggests that Wall Street has decided who the winner is in the HIT game. As my Fiercehealthcare editorial last week suggested, it’s probably a matter of when rather than if one of the bigger tech companies (Oracle is a persistent rumor) decides that they want them. However, at a PE of 37, Cerner is pretty pricey!
My next real work is on the subject of ePrescribing. So if that’s an interest of yours please drop me an email. Hope you didn’t miss me too much, and I look forward to being a little more attentive in the coming weeks.